Contact
Please use this form to send email to PR contact of this press release:
ThromboGenics NV : ThromboGenics Regains Global Rights to JETREA® (ocriplasmin)
TO:
Please use this form to send email to PR contact of this press release:
ThromboGenics NV : ThromboGenics Regains Global Rights to JETREA® (ocriplasmin)
TO: